112 related articles for article (PubMed ID: 1316968)
21. Reversible inhibitors of the gastric (H+/K+)-ATPase. 4. Identification of an inhibitor with an intermediate duration of action.
Leach CA; Brown TH; Ife RJ; Keeling DJ; Parsons ME; Theobald CJ; Wiggall KJ
J Med Chem; 1995 Jul; 38(14):2748-62. PubMed ID: 7629813
[TBL] [Abstract][Full Text] [Related]
22. The H+/ATP stoichiometry of the (H+ +K+)-ATPase of dog gastric microsomes.
Smith GS; Scholes PB
Biochim Biophys Acta; 1982 Jun; 688(3):803-7. PubMed ID: 6288094
[TBL] [Abstract][Full Text] [Related]
23. A K(+)-competitive fluorescent inhibitor of the H,K-ATPase.
Rabon E; Sachs G; Bassilian S; Leach C; Keeling D
J Biol Chem; 1991 Jul; 266(19):12395-401. PubMed ID: 1648097
[TBL] [Abstract][Full Text] [Related]
24. Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.
LaMattina JL; McCarthy PA; Reiter LA; Holt WF; Yeh LA
J Med Chem; 1990 Feb; 33(2):543-52. PubMed ID: 2153817
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
Wallmark B; Sachs G; Mardh S; Fellenius E
Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
[TBL] [Abstract][Full Text] [Related]
26. Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility.
Takahashi N; Take Y
J Pharmacol Exp Ther; 2018 Feb; 364(2):275-286. PubMed ID: 29180359
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of gastric H+,K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib.
Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
Biochem Pharmacol; 1992 Jul; 44(1):33-7. PubMed ID: 1321629
[TBL] [Abstract][Full Text] [Related]
28. Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase.
Adelstein GW; Yen CH; Haack RA; Yu S; Gullikson G; Price DV; Anglin C; Decktor DL; Tsai H; Keith RH
J Med Chem; 1988 Jun; 31(6):1215-20. PubMed ID: 2836591
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
Freitas CS; Baggio CH; Finau J; Anginoni M; Pizzolatti MG; Santos AR; Marques MC
J Pharm Pharmacol; 2008 Aug; 60(8):1105-10. PubMed ID: 18644203
[TBL] [Abstract][Full Text] [Related]
30. Role of membrane-associated thiol groups in the functional regulation of gastric microsomal (H+ + K+)-transporting ATPase system.
Nandi J; Meng-Ai Z; Ray TK
Biochem J; 1983 Sep; 213(3):587-94. PubMed ID: 6311168
[TBL] [Abstract][Full Text] [Related]
31. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
Kaminski JJ; Wallmark B; Briving C; Andersson BM
J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
[TBL] [Abstract][Full Text] [Related]
32. 2-[[(4-Amino-2-pyridyl)methyl]sulfinyl]benzimidazole H+/K+-ATPase inhibitors. The relationship between pyridine basicity, stability, and activity.
Ife RJ; Dyke CA; Keeling DJ; Meenan E; Meeson ML; Parsons ME; Price CA; Theobald CJ; Underwood AH
J Med Chem; 1989 Aug; 32(8):1970-7. PubMed ID: 2547073
[TBL] [Abstract][Full Text] [Related]
33. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
34. Reaction mechanism of the gastric H+ +K+-dependent ATPase. Effects of inhibitor and pH.
Nandi J; Ray TK
Biochem J; 1987 Jan; 241(1):175-81. PubMed ID: 3032153
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of a pure endogenous activator of the gastric H+,K+-ATPase system. Evaluation of the role as a possible intracellular regulator.
Bandopadhyay S; Das PK; Wright MV; Nandi J; Bhattacharyyay D; Ray TK
J Biol Chem; 1987 Apr; 262(12):5664-70. PubMed ID: 3032941
[TBL] [Abstract][Full Text] [Related]
36. BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.
Kromer W; Postius S; Riedel R; Simon WA; Hanauer G; Brand U; Gönne S; Parsons ME
J Pharmacol Exp Ther; 1990 Jul; 254(1):129-35. PubMed ID: 2164086
[TBL] [Abstract][Full Text] [Related]
37. Studies on proton pump inhibitors. I. Synthesis of 8-[(2-benzimidazolyl)sulfinyl]-5,6,7,8-tetrahydroquinolines and related compounds.
Uchida M; Morita S; Chihiro M; Kanbe T; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1517-23. PubMed ID: 2550154
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationships of substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors. II.
Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Harada H; Okabe S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):675-82. PubMed ID: 1319287
[TBL] [Abstract][Full Text] [Related]
39. The catalytic cycle of gastric (H+ + K+)-ATPase.
Wallmark B; Stewart HB; Rabon E; Saccomani G; Sachs G
J Biol Chem; 1980 Jun; 255(11):5313-9. PubMed ID: 6102997
[No Abstract] [Full Text] [Related]
40. Binding site of omeprazole in hog gastric H+,K(+)-ATPase.
Morii M; Takata H; Takeguchi N
Biochem Biophys Res Commun; 1990 Mar; 167(2):754-60. PubMed ID: 2157414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
